EAH
VERY GOODECO Animal Health Delivers EBITDA Ahead of Expectations
The animal health company reports EBITDA ahead of market forecasts, driven by strong gross margins and cost control.
ECO Animal Health Group
60.00GBX
12.15%
Market Cap
40.66M
Volume
16.6k
26% of avg
P/E Ratio
0.28
EPS (TTM)
2.11
Beta
0.03
Day Range
0.00p - 0.00p
52 Week Range
0.00p60.00p135.00p
60.00p
Upcoming Events
July 2025
Full Year Results
High Impact Event
September 2026
Expected EMA approval decision for ECOVAXXIN® Mycoplasma synoviae vaccine
High Impact Event
EAH
GOODECO Animal Health Hosts R&D Day to Showcase Pipeline
The healthcare company is hosting an R&D Day to showcase its pipeline of new veterinary products and how they will drive future growth.
EAH
NEUTRALECO Animal Health Submits First EU Vaccine Application for Regulatory Approval
The healthcare company has submitted its first EU vaccine application for regulatory approval, marking an important milestone in its R&D pipeline.
EAH
NEUTRALECO Animal Health Group PLC: Routine Shareholding Notification
The retailer has announced a routine regulatory notification of a change in shareholding, with no material impact on the business.
EAH
NEUTRALECO Animal Health Streamlines Focus with Disposal of Non-Core Assets
The healthcare company has sold non-core product lines to its South African distribution partner for £491,000, allowing it to focus on its core pigs and poultry business and reinvest in R&D.
EAH
NEUTRALECO Animal Health Group Announces R&D Day for Investors
The animal health company is hosting an R&D Day for investors to showcase its pipeline and long-term value creation.
EAH
NEUTRALECO Animal Health Announces Planned Board Changes
The animal health company announces the retirement of its long-serving Chairman and the appointment of a new Chairman with extensive industry experience, as part of a planned succession process.
EAH
NEUTRALECO Animal Health Sees Routine Shareholding Change
Routine shareholding change announcement for this small-cap pharmaceutical company, with no significant impact on the business.
EAH
NEUTRALECO Animal Health Group Announces Change in Major Shareholding
The pharmaceutical company has announced a change in major shareholding, with Killik & Co LLP acquiring a 3.013800% stake.
EAH
GOODECO Animal Health CEO Buys Shares, Signaling Confidence
A global animal health company with a portfolio of veterinary products and a maturing R&D pipeline sees its CEO increase his stake.